Powder: -20°C for 3 years | In solvent: -80°C for 1 year
SGC-CBP30 is an effective CREBBP/EP300 inhibitor (IC50: 21/38 nM).
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
1 mg | In stock | $ 45.00 | |
2 mg | In stock | $ 65.00 | |
5 mg | In stock | $ 80.00 | |
10 mg | In stock | $ 122.00 | |
25 mg | In stock | $ 222.00 | |
50 mg | In stock | $ 372.00 | |
100 mg | In stock | $ 556.00 | |
1 mL * 10 mM (in DMSO) | In stock | $ 90.00 |
Description | SGC-CBP30 is an effective CREBBP/EP300 inhibitor (IC50: 21/38 nM). |
Targets&IC50 | CREBBP:21 nM, EP300:38 nM |
In vivo | SGC-CBP30 exhibits moderate cytotoxicity in U2OS and HeLa cells. |
Molecular Weight | 509.04 |
Formula | C28H33ClN4O3 |
CAS No. | 1613695-14-9 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
H2O: < 1 mg/mL (insoluble or slightly soluble)
Ethanol: 93 mg/mL (182.7 mM)
DMSO: 93 mg/mL (182.7 mM)
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
SGC-CBP30 1613695-14-9 Chromatin/Epigenetic Histone Acetyltransferase Epigenetic Reader Domain inhibit IL-17A HAT HATs BRD ankylosing SGCCBP30 cells epigenetic spondylitis anti-inflammatory arthritis SGC-CBP-30 Th17 psoriatic SGC CBP30 Inhibitor inhibitor